Topics discussedWhich segments and countries have recovered to pre-pandemic levels?Which segments are poised for strong growth post covid? What are these drivers?What domestic players have risen and are well positioned for sustainable growth?Post pandemic healthcare changesGetting ready to win in a new era of IVDPresenter: Chee Hew, Director, Data Analytics & Consulting, ClearstateDate &Time: 4:00 PM SGT / 9:00 am BST, 20th October 2022 Watch on demand
Case study Uncovering opportunities faster with IVD Size & Share Plus In dynamic market segments such as infectious disease testing, demand for IVD testing can change quickly and gaining clarity on future demand is a big challenge for the client, an IVD company. In-vitro diagnostics | Global | IVD Gateway | Size and Share Plus
Case study Support strategic market planning with IVD Size & Share Plus In-vitro diagnostics | Uncategorised | Global | IVD Gateway | Size and Share Plus
Clearstate Insights How Indonesia’s healthcare transformation will impact its IVD market Centralised Diagnostics (CEDx) | In-vitro diagnostics | Molecular Diagnostics (MDx) | Point-of-care testing (POCT) | Asia | Centralised Diagnostics (CEDx) | IVD Gateway | Molecular Diagnostics (MDx) | Point-of-care testing (POCT)
Clearstate Insights APAC IVD market to shrink by 2026 as demand for covid-19 testing cools further In-vitro diagnostics | Asia | IVD Gateway
IVD GatewayThe go-to source for tracking and understanding market size, share and trends in IVD. Granular break-out of data and comprehensive coverage of international and domestic suppliers’ brand share across Asia, Europe, Latin America and the Middle East. Find out more